Skip to main content

Table 1 Clinicopathology of patients used for patient-derived organoids

From: A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases

Patient no. Age, yr Gender CEA, ng/ml Tumor location TNM stage Metastatic organ
mCRC
 1# 60 Female 2644.3 Sigmoid IV Liver
 2# 61 Male 122.4 Rectum IV Liver, Lung
 3# 64 Male 546.0 Ascending IV Liver
 4# 69 Male 3555.4 Rectum IV Liver
 5# 64 Male 46.2 Descending IV Liver
 6# 64 Female 3.2 Ascending IV Liver, Lung
CRC
 7# 69 Male 77.3 Rectum III None
 8# 64 Male 14.6 Descending III None
 9# 67 Male 262.8 Sigmoid III None
 10# 64 Female 5.3 Ascending III None
 11# 65 Female 36.6 Rectum II None
 12# 69 Male 4.4 Sigmoid II None